NCT00434681View on ClinicalTrials.gov

Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2006

Study Completion Date

April 30, 2007

Conditions
FeverPain
Interventions
DRUG

paracetamol 4.8% paediatric oral suspension

Trial Locations (1)

Unknown

Sanofi-Aventis, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00434681 - Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety. | Biotech Hunter | Biotech Hunter